PPARA and neoplasm: Adoptive transfer of splenocytes from syngeneic mice bearing MC38 colon tumors treated and cured with TPST-1120 plus anti-PD-1 conferred resistance to tumor challenge in naïve mice, similar to the results observed in Ppara KO studies (16).